Arvee Syntthesis Profile
Key Indicators
- Authorised Capital ₹ 3.52 Cr
as on 07-07-2024
- Paid Up Capital ₹ 3.52 Cr
as on 07-07-2024
- Company Age 37 Year, 28 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 9.84 Cr
as on 07-07-2024
- Revenue -62.34%
(FY 2023)
- Profit -84.90%
(FY 2023)
- Ebitda -84.03%
(FY 2023)
- Net Worth 0.16%
(FY 2023)
- Total Assets 0.53%
(FY 2023)
About Arvee Syntthesis
The Corporate was formerly known as Arvee Chem Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.52 Cr and a paid-up capital of Rs 3.52 Cr.
The company has closed loans amounting to ₹9.84 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mohan Rao and Mamatha Mohan serve as directors at the Company.
- CIN/LLPIN
U51397KA1987PTC008749
- Company No.
008749
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Nov 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Jayalakshmipuram, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media
Who are the key members and board of directors at Arvee Syntthesis?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Rao  | Managing Director | 24-Nov-1987 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mamatha Mohan | Whole-Time Director | 02-Mar-1990 | Current |
Financial Performance of Arvee Syntthesis.
Arvee Syntthesis Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 62.34% decrease. The company also saw a substantial fall in profitability, with a 84.9% decrease in profit. The company's net worth moved up by a moderate rise of 0.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arvee Syntthesis?
In 2023, Arvee Syntthesis had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Mysore Creation Date: 15 Sep 2008 | ₹8.65 Cr | Satisfied |
M/S Karnataka State Financial Corporation Creation Date: 26 Mar 2004 | ₹6.40 M | Satisfied |
K.S.F.C. Creation Date: 12 Oct 2002 | ₹5.00 M | Satisfied |
How Many Employees Work at Arvee Syntthesis?
Unlock and access historical data on people associated with Arvee Syntthesis, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arvee Syntthesis, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arvee Syntthesis's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
